BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 21, 2011
View Archived Issues
Histamine H3 receptor antagonist JNJ-39220675 shows promise against alcoholism
Read More
Resminostat advances in phase I/II SHORE trial in colorectal cancer
Read More
BioMarin begins phase I/II trial of BMN-701 in late-onset Pompe's disease
Read More
Chinese scientists develop polycaprolactone-magnesium scaffold for bone repair
Read More
Masitinib mesilate prolongs survival of imatinib-naive subjects with advanced/metastatic GIST
Read More
Xybrex has analgesic activity in subjects undergoing iliac crest bone graft harvesting
Read More
Scientists identify satellite repeats in heterochromatin that are overexpressed in epithelial cancer
Read More
MycoVa demonstrates noninferiority to Loceryl in onychomycosis
Read More
Transcept resubmits Intermezzo NDA for insomnia to FDA
Read More
New activators of pyruvate kinase isozymes M1/M2 claimed
Read More
AstraZeneca presents new beta-secretase 1 inhibitors
Read More
Auspex Pharma patents new beta3-adrenoceptor modulators
Read More
New glucocorticoid receptor agonists discovered
Read More
FDA and Health Canada grant telaprevir priority review for HCV infection
Read More
Amicus Therapeutics announces milestones expected for 2011
Read More
Evotec and Takeda Cambridge join to identify GPCR and protease modulators
Read More
Geron begins phase II trial of imetelstat in essential thrombocythemia
Read More
Theraclone and Pfizer to codevelop antibodies against infectious disease and cancer targets
Read More
FDA sets PDUFA date for Adventrx's Exelbine NDA
Read More
NerBloc approved in Japan for treatment of cervical dystonia
Read More
CHMP issues positive opinion on European orphan drug status for darinaparsin in PTCL
Read More
Phase III data reported on levomilnacipran in major depressive disorder
Read More
New osteoporosis drug Edirol approved in Japan
Read More
Daiichi Sankyo's Alzheimer's disease treatment Memary approved in Japan
Read More
Health Canada approves once-daily antidepressant Oleptro
Read More
